Association of Incremental peritoneal dialysis with residual kidney function decline in patients on peritoneal dialysis: The balANZ trial

Author:

Hayat Ashik123ORCID,Cho Yeoungjee123ORCID,Hawley Carmel M123,Htay Htay4ORCID,Krishnasamy Rathika25,Pascoe Elaine2,Teitelbaum Isaac6ORCID,Varnfield Marliene27,Johnson David W123ORCID

Affiliation:

1. Department of Kidney and Transplant Services, Princess Alexandra Hospital, Brisbane, Australia

2. Australasian Kidney Trials Network, The University of Queensland, Brisbane, Australia

3. Translational Research Institute, Brisbane, Australia

4. Department of Renal Medicine, Singapore General Hospital, Singapore

5. Sunshine Coast University Hospital, Queensland, Australia

6. Division of Nephrology, Department of Medicine, University of Colorado, Aurora, USA

7. Australian e-Health Research Centre, CSIRO, Brisbane, Australia

Abstract

Background: Incremental peritoneal dialysis (PD), defined as less than Full-dose PD prescription, has several possible merits, including better preservation of residual kidney function (RKF), lower peritoneal glucose exposure and reduced risk of peritonitis. The aims of this study were to analyse the association of Incremental and Full-dose PD strategy with RKF and urine volume (UV) decline in patients commencing PD. Methods: Incident PD patients who participated in the balANZ randomised controlled trial (RCT) (2004–2010) and had at least one post-baseline RKF and UV measurement was included in this study. Patients receiving <56 L/week and ≥56 L/week of PD fluid at PD commencement were classified as Incremental and Full-dose PD, respectively. An alternative cut-point of 42 L/week was used in a sensitivity analysis. The primary and secondary outcomes were changes in measured RKF and daily UV, respectively. Results: The study included 154 patients (mean age 57.9 ± 14.1 years, 44% female, 34% diabetic, mean follow-up 19.5 ± 6.6 months). Incremental and Full-dose PD was commenced by 45 (29.2%) and 109 (70.8%) participants, respectively. RKF declined in the Incremental group from 7.9 ± 3.2 mL/min/1.73 m2 at baseline to 3.2 ± 2.9 mL/min/1.73 m2 at 24 months ( p < 0.001), and in the Full-dose PD group from 7.3 ± 2.7 mL/min/1.73 m2 at baseline to 3.4 ± 2.8 mL/min/1.73 m2 at 24 months ( p < 0.001). There was no difference in the slope of RKF decline between Incremental and Full-dose PD ( p = 0.78). UV declined from 1.81 ± 0.73 L/day at baseline to 0.64 ± 0.63 L/day at 24 months in the Incremental PD group ( p < 0.001) and from 1.38 ± 0.61 L/day to 0.71 ± 0.46 L/day in the Full-dose PD group ( p < 0.001). There was no difference in the slope of UV decline between Incremental and Full-dose PD ( p = 0.18). Conclusions: Compared with Full-dose PD start, Incremental PD start is associated with similar declines in RKF and UV.

Publisher

SAGE Publications

Subject

Nephrology,General Medicine

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Incremental peritoneal dialysis: Incremental gains;Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3